Insider Transactions in Q4 2025 at Solid Biosciences Inc. (SLDB)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
Alexander Cumbo President and CEO |
SELL
Open market or private sale
|
Direct |
10,808
-11.72%
|
$54,040
$5.11 P/Share
|
|
Dec 03
2025
|
David T Howton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,932
-13.03%
|
$24,660
$5.11 P/Share
|
|
Dec 03
2025
|
Paul Herzich Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,701
-9.21%
|
$13,505
$5.11 P/Share
|
|
Dec 03
2025
|
Jessie Hanrahan Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
4,483
-14.39%
|
$22,415
$5.11 P/Share
|
|
Dec 02
2025
|
Alexander Cumbo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,612
+23.68%
|
-
|
|
Dec 02
2025
|
David T Howton Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,051
+25.65%
|
-
|
|
Dec 02
2025
|
Paul Herzich Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,239
+19.8%
|
-
|
|
Dec 02
2025
|
Jessie Hanrahan Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,862
+27.58%
|
-
|
|
Nov 10
2025
|
Ilan Ganot |
SELL
Open market or private sale
|
Direct |
3,278
-3.32%
|
$13,112
$4.12 P/Share
|
|
Oct 20
2025
|
Gabriel Brooks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,895
-7.89%
|
$14,475
$5.96 P/Share
|
|
Oct 18
2025
|
Gabriel Brooks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,750
+20.98%
|
-
|
|
Oct 06
2025
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
4,573
+3.48%
|
-
|